BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19960158)

  • 1. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians.
    Wee WW; Kanagalingam D
    Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
    Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
    Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; DĂ©silets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ; Findlay J; Thompson K; Roseman F
    BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
    Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 7. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
    Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
    Tuohy JF; Sangalli M; Kim L
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
    Chaffe B; Ford J; Bills V
    Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohematological surveillance of the pregnant woman: new prevention policy].
    Mannessier L
    Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-erythrocyte alloimmunization in an obstetrical milieu. Study of 2093 cases].
    Gargouri J; Khemiri H; Feki H; Rekik H; Rekik S
    Tunis Med; 2002 May; 80(5):255-9. PubMed ID: 12534028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antenatal anti-Rh(D) antigen prophylaxis].
    Katsulov A;
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.